Skip to main content
Premium Trial:

Request an Annual Quote

Signature Dx to Launch Two Colorectal Tests on Affy Platform

Premium

By Justin Petrone

German test developer Signature Diagnostics this week said it has obtained a worldwide license to use Affymetrix's GeneChip microarray platform to develop and commercialize its tests for colorectal cancer. The deal is part of Affy's 'Powered by Affymetrix' program.

Potsdam-based Signature Dx plans to launch by the fourth quarter of this year two array-based in vitro diagnostics for colorectal cancer. The company will first launch the tests in Europe and intends to seek US regulatory approval at an unspecified time in the future.

Signature Dx's tests are called Detector C and Predictor C. Detector C is a non-invasive, blood-based early detection test that evaluates the expression of 202 genes that are altered in response to tumor formation and growth. The test has demonstrated 90 percent sensitivity and 88 percent specificity for all four stages of colorectal cancer, according to the company. The Predictor C test evaluates the expression of 32 genes that predict disease progression in stage II and III colorectal cancer patients and has been shown to identify half of all stage II/III patients with a high risk of disease progression, the company said.

"Our novel Detector C blood screening product together with Affymetrix's gene expression array technology brings CRC screening to a new level of accuracy and sensitivity," André Rosenthal, CEO of Signature Diagnostics, said in a statement

Rosenthal did not reply to an e-mail seeking additional comment.

Financial terms of the agreement were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.